CEPI (Coalition for Epidemic Preparedness Innovations)

The Coalition for Epidemic Preparedness Innovations (CEPI) is a global partnership launched in 2017 to accelerate the development of vaccines against emerging infectious diseases. CEPI’s mission is to ensure that vaccines are developed and made available to populations at risk, particularly in low- and middle-income countries.

CEPI works collaboratively with various stakeholders, including governments, non-profit organizations, and the private sector, to foster innovation in vaccine research and development. By funding and supporting vaccine candidates, CEPI aims to reduce the time it takes to respond to outbreaks of infectious diseases.

One of CEPI’s key initiatives is the establishment of a robust platform for vaccine development that can be rapidly mobilized during an epidemic. This platform allows for the swift design, testing, and production of vaccines, ensuring that they are ready when needed most.

CEPI also focuses on building a sustainable ecosystem for vaccine development by investing in research and technology. Through partnerships with leading scientific institutions and pharmaceutical companies, CEPI seeks to advance the science of vaccinology.

In addition to its core activities, CEPI plays a vital role in global health security by advocating for equitable access to vaccines. CEPI believes that no one should be left behind in the fight against epidemics, and it actively works to ensure that vaccines reach vulnerable populations.

With its headquarters in the UK, CEPI is strategically positioned to collaborate with international health organizations and governments worldwide. CEPI’s vision is to create a world where epidemics are effectively managed through timely and equitable access to vaccines, ultimately saving lives and protecting communities.